Applications: Used for the quantitative determination of Elezanumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 223.20 ng/mL
Range: 312.5 - 20,000 ng/mL
Applications: Used for the quantitative determination of Tezepelumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 88.43 ng/mL
Range: 125 - 8,000 ng/mL
Applications: Used for the quantitative determination of Lodelcizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 241.13 ng/mL
Range: 468.75 - 30,000 ng/mL
Applications: Used for the quantitative determination of Frovocimab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 4.31 ng/mL
Range: 8.78 - 100 ng/mL
Applications: Used for the quantitative determination of Omburtamab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 108.57 ng/mL
Range: 156.25 - 10,000 ng/mL
Applications: Used for the quantitative determination of Mirzotamab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 45.23 ng/mL
Range: 93.75 - 6,000 ng/mL
Applications: Used for the quantitative determination of Enoblituzumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 175.65 ng/mL
Range: 312.5 - 20,000 ng/mL
Applications: Used for the quantitative determination of Tiragolumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 21.35 ng/mL
Range: 31.25 - 2,000 ng/mL
Applications: Used for the quantitative determination of Vunakizumab concentration in serum and plasma.
Sample type: Plasma, Serum
Sensitivity: 51.46 ng/mL
Range: 93.75 - 6,000 ng/mL
